Attitudes of psychiatrists towards people with mental illness: a cross-sectional, multicentre study of stigma in 32 European countries.

Attitude of psychiatrists Help-seeking psychiatrist Mental health-related stigma Opening minds stigma scale Psychiatrist stigma Stigmatising attitude

Journal

EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 15 08 2023
revised: 09 11 2023
accepted: 15 11 2023
medline: 27 12 2023
pubmed: 27 12 2023
entrez: 27 12 2023
Statut: epublish

Résumé

Mental health-related stigma occurs among the public and professionals alike. The lived experience of mental illness has been linked to less stigmatising attitudes. However, data on psychiatrists and the relationship between stigmatising attitudes and psychotherapeutic activity or case discussion groups remains scarce. A cross-sectional multicentre study was performed in 32 European countries to investigate the lived experiences and attitudes of psychiatrists toward patients with mental illness as well as the relationship between stigma, psychosocial and professional factors. The self-reported, anonymous, internet-based Opening Minds Stigma Scale for Health Care Providers was used to measure the stigmatising attitudes. The survey was translated into the local language of each participating country. All participants were practising specialists and trainees in general adult or child and adolescent psychiatry. The study took place between 2nd October, 2019 and 9th July, 2021 and was preregistered at ClinicalTrial.gov (NCT04644978). A total of 4245 psychiatrists completed the survey. The majority, 2797 (66%), had completed training in psychiatry, and 3320 (78%) worked in adult psychiatry. The final regression model showed that across European countries more favourable attitudes toward people with mental illness were statistically significantly associated with the lived experience of participants (including seeking help for their own mental health conditions (d = -0.92, 95% confidence interval (CI) = -1.68 to -0.15, p = 0.019), receiving medical treatment for a mental illness (d = -0.88, 95% CI = -1.71 to -0.04, p = 0.040), as well as having a friend or a family member similarly affected (d = -0.68, 95% CI = -1.14 to -0.22, p = 0.004)), being surrounded by colleagues who are less stigmatising (d = -0.98, 95% CI = -1.26 to -0.70, p < 0.001), providing psychotherapy to patients (d = -1.14, 95% CI = -1.63 to -0.65 p < 0.001), and being open to (d = -1.69, 95% CI = -2.53 to -0.85, p < 0.001) and actively participating in (d = -0.94, 95% CI = -1.45 to -0.42, p < 0.001) case discussion, supervision, or Balint groups. Our study highlights the importance of psychotherapy training, supervision, case discussions and Balint groups in reducing the stigmatising attitudes of psychiatrists toward patients. As the findings represent cross-national predictors, Europe-wide policy interventions, national psychiatric education systems and the management of psychiatric institutions should take these findings into consideration. National Youth Talent Award (Ministry of Human Resources, Hungary, (NTP-NFTÖ-20-B-0134). All authors received no funding for their contribution.

Sections du résumé

Background UNASSIGNED
Mental health-related stigma occurs among the public and professionals alike. The lived experience of mental illness has been linked to less stigmatising attitudes. However, data on psychiatrists and the relationship between stigmatising attitudes and psychotherapeutic activity or case discussion groups remains scarce.
Methods UNASSIGNED
A cross-sectional multicentre study was performed in 32 European countries to investigate the lived experiences and attitudes of psychiatrists toward patients with mental illness as well as the relationship between stigma, psychosocial and professional factors. The self-reported, anonymous, internet-based Opening Minds Stigma Scale for Health Care Providers was used to measure the stigmatising attitudes. The survey was translated into the local language of each participating country. All participants were practising specialists and trainees in general adult or child and adolescent psychiatry. The study took place between 2nd October, 2019 and 9th July, 2021 and was preregistered at ClinicalTrial.gov (NCT04644978).
Findings UNASSIGNED
A total of 4245 psychiatrists completed the survey. The majority, 2797 (66%), had completed training in psychiatry, and 3320 (78%) worked in adult psychiatry. The final regression model showed that across European countries more favourable attitudes toward people with mental illness were statistically significantly associated with the lived experience of participants (including seeking help for their own mental health conditions (d = -0.92, 95% confidence interval (CI) = -1.68 to -0.15, p = 0.019), receiving medical treatment for a mental illness (d = -0.88, 95% CI = -1.71 to -0.04, p = 0.040), as well as having a friend or a family member similarly affected (d = -0.68, 95% CI = -1.14 to -0.22, p = 0.004)), being surrounded by colleagues who are less stigmatising (d = -0.98, 95% CI = -1.26 to -0.70, p < 0.001), providing psychotherapy to patients (d = -1.14, 95% CI = -1.63 to -0.65 p < 0.001), and being open to (d = -1.69, 95% CI = -2.53 to -0.85, p < 0.001) and actively participating in (d = -0.94, 95% CI = -1.45 to -0.42, p < 0.001) case discussion, supervision, or Balint groups.
Interpretation UNASSIGNED
Our study highlights the importance of psychotherapy training, supervision, case discussions and Balint groups in reducing the stigmatising attitudes of psychiatrists toward patients. As the findings represent cross-national predictors, Europe-wide policy interventions, national psychiatric education systems and the management of psychiatric institutions should take these findings into consideration.
Funding UNASSIGNED
National Youth Talent Award (Ministry of Human Resources, Hungary, (NTP-NFTÖ-20-B-0134). All authors received no funding for their contribution.

Identifiants

pubmed: 38149261
doi: 10.1016/j.eclinm.2023.102342
pii: S2589-5370(23)00519-9
pmc: PMC10749877
doi:

Banques de données

ClinicalTrials.gov
['NCT04644978']

Types de publication

Journal Article

Langues

eng

Pagination

102342

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

DŐ received the National Youth Talent Award in 2020 and 2021 (Ministry of Human Resources, Hungary, (NTP-NFTÖ-20-B-0134 and NTP-NFTÖ-21-B-0280) that covered the membership fee for one year of the online survey platform, and the expenses of the dissemination of the results at international congresses. She received grants from the Fulbright Program in 2022, the Semmelweis 250+ Excellence PhD Scholarship in 2023 and the New National Excellence Program in 2023 (ÚNKP-23-III-2). She received support for travel from Kerpel-Fronius Talent Support Program of Semmelweis University in 2022 and 2023 (EFOP-3.6.3-VEKOP-16-2017-00009). She is a medical Secretariat at the Hungarian Psychiatric Association. The article processing charge is covered by the Semmelweis University. SMa received a grant to attend the World Congress of Psychiatry (WPA) in 2022 and 2023 from the World Psychiatric Association. She is the Vice-chair of Psychiatric trainees committee (2020–2021) of the Royal College of Psychiatrists (UK). MW is the past president of the European Federation of Psychaitric Trainees. He is a Co-president of the Verband der Schweizerischen Assistenz—und Oberarzte (Association of Swiss Assistant and Senior Physicians) Section Thuragu. SRó received support from The Károli Gáspár University of the Reformed Church for the statistical analyses carried out (Grant No. 20754B800). Other authors declare no competing financial interests.

Auteurs

Dorottya Őri (D)

Institute of Behavioural Sciences, Semmelweis University, Budapest, Hungary.
Department of Mental Health, Heim Pál National Pediatric Institute, Budapest, Hungary.

Péter Szocsics (P)

Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.

Tamás Molnár (T)

Department of Psychiatry, Aladar Petz County Teaching Hospital, Győr, Hungary.

Lucie Bankovska Motlova (LB)

Division of Medical Psychology, 3rd Faculty of Medicine, Charles University, Prague, The Czech Republic.

Olga Kazakova (O)

Inpatient Psychiatric Department #2, Psychiatric Clinic of Minsk City, Minsk, Belarus.

Sabrina Mörkl (S)

Division of Medical Psychology, Psychosomatics and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.

Michael Wallies (M)

Therapie auf Augenhoehe, Buelach, Switzerland.

Mohamed Abdulhakim (M)

Department of Psychiatry, Vrije Universiteit Brussel, Brussels, Belgium.

Sylvie Boivin (S)

Department of Child and Adolescent Psychiatry, EPSM du Finistère Sud, Quimper, France.

Krista Bruna (K)

Admission Ward, State Psychiatric Hospital Gintermuiza, Jelgava, Latvia.

Carolina Cabaços (C)

Psychiatry Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Institute of Psychological Medicine, Faculty of Medicine, Coimbra University, Coimbra, Portugal.
Coimbra Institute for Biomedical Imaging and Translational Research, Coimbra, Portugal.

Elvira Anna Carbone (EA)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy.

Elona Dashi (E)

Department of Neuroscience, University Hospital Center "Mother Theresa", Tirane, Albania.

Giovanni Grech (G)

Mental Health Services, Mount Carmel Hospital, Attard, Malta.

Stjepan Greguras (S)

Division of Child and Adolescent Psychiatry and Psychotherapy, Department of Psychiatry and Psychological Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.

Iva Ivanovic (I)

Department for Child Psychiatry, Institute for Children's Diseases, Clinical Centre of Montenegro, Podgorica, Montenegro.

Kaloyan Guevara (K)

Acute Detoxification Ward, State Psychiatric Hospital for Treatment of Drug Addiction and Alcoholism, Sofia, Bulgaria.

Selay Kakar (S)

Department of Psychiatry, Erasmus University Medical Center, Rotterdam, the Netherlands.

Konstantinos Kotsis (K)

Department of Psychiatry, University of Ioannina, Ioannina, Greece.

Ida Maria Ingeholm Klinkby (IM)

Department of Child and Adolescent Psychiatry, Capital Region of Denmark, Copenhagen, Denmark.

Jovana Maslak (J)

Department of Mental Health, Belgrade, Serbia.

Shevonne Matheiken (S)

Pennine Care NHS Foundation Trust, Oldham, United Kingdom.

Ana Mirkovic (A)

Child Psychiatry Unit, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Nikita Nechepurenko (N)

The Serbsky State Scientific Center for Social and Forensic Psychiatry, Moscow, Russian Federation.

Angelis Panayi (A)

Freelancer, Larnaca, Cyprus.

Ana Telma Pereira (AT)

Institute of Psychological Medicine, Faculty of Medicine, Coimbra University, Coimbra, Portugal.
Coimbra Institute for Biomedical Imaging and Translational Research, Coimbra, Portugal.

Edith Pomarol-Clotet (E)

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
Centro de Investigacion Biomedica en Red de Salud Mental, Instituto de Salud Carlos III, Barcelona, Spain.

Shaeraine Raaj (S)

Department of General Adult Psychiatry, South Meath Mental Health Service, Co.Meath, Ireland.

Polona Rus Prelog (PR)

Centre for Clinical Psychiatry, University Psychiatric Clinic Ljubljana, Ljubljana, Slovenia.

Joan Soler-Vidal (J)

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
Centro de Investigacion Biomedica en Red de Salud Mental, Instituto de Salud Carlos III, Barcelona, Spain.
Hospital Benito Menni, Complex Assistencial Salut Mental, Sant Boi de Llobregat, Spain.

Robertas Strumila (R)

Department of Urgent and Post Urgent Psychiatry, CHU Montpellier, Montpellier, France.
Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.
Psychiatric Clinic, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.

Florian Schuster (F)

Klinikum Rechts der Isar der Technischen Universität München: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, Munich, Germany.

Helena Kisand (H)

University of Tartu, Tartu, Estonia.

Ann Reim (A)

University of Tartu, Tartu, Estonia.

Gumru Ahmadova (G)

Department of Psychiatry, United City Hospital N15, Baku, Azerbaijan.

Matus Vircik (M)

Acute Psychiatric Department 1, Psychiatric Hospital Michalovce, Michalovce, Slovak Republic.

Helin Yilmaz Kafali (HY)

Department of Psychology, Fevziye School Fundatitions, Işık University, Istanbul, Turkey.

Natalia Grinko (N)

Department of Clinical Psychology, Ukrainian Catholic University, Lviv, Ukraine.

Zsuzsa Győrffy (Z)

Institute of Behavioural Sciences, Semmelweis University, Budapest, Hungary.

Sándor Rózsa (S)

Department of Personality and Health Psychology, Károli Gáspár University of the Reformed Church, Budapest, Hungary.

Classifications MeSH